- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/06 - Peri-condensed systems
Patent holdings for IPC class C07D 498/06
Total number of patents in this class: 316
10-year publication summary
|
29
|
17
|
25
|
13
|
17
|
12
|
16
|
17
|
24
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4826 |
20 |
| Incyte Holdings Corporation | 663 |
14 |
| Merck Patent GmbH | 5752 |
11 |
| Samsung Display Co., Ltd. | 36317 |
7 |
| LG Chem, Ltd. | 17706 |
7 |
| Incyte Corporation | 1039 |
7 |
| Genentech, Inc. | 4016 |
5 |
| Janssen Pharmaceutica N.V. | 3358 |
5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 722 |
5 |
| KYORIN Pharmaceutical Co., Ltd. | 169 |
5 |
| Adlai Nortye Biopharma Co., Ltd. | 65 |
5 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
4 |
| CTI Biopharma Corp. | 30 |
4 |
| Rigel Pharmaceuticals, Inc. | 530 |
4 |
| Onkure, Inc. | 29 |
4 |
| Jubilant Epipad LLC | 11 |
4 |
| Canon Inc. | 41151 |
3 |
| Vertex Pharmaceuticals Incorporated | 1630 |
3 |
| Daiichi Sankyo Company, Limited | 1879 |
3 |
| King's College London | 547 |
3 |
| Other owners | 193 |